Drug major
Cipla on Wednesday reported a 7 per cent increase in its consolidated net profit to Rs 808 crore for the third quarter that ended December 2022, aided by robust sales. The Mumbai-based drug maker had reported a net profit of Rs 757 crore for the October-December period of the last
fiscal.
Its total
revenue from operations rose to Rs 5,810 crore for the third quarter compared to Rs 5,479 in the year-ago period, Cipla said in a regulatory filing.
For the nine months ended December 31, 2022, the company reported a net profit of Rs 2,311 crore against Rs 2,176 crore in the same period last fiscal.
Shares of the company were trading 2.73 per cent down at Rs 1,032.50 apiece on the
BSE.
SEE ALSO:
Airtel price hike announced – customers will have to pay 57% more for the telco’s cheapest plan
Elon Musk, Warren Buffet, Gautam Adani, Mukesh Ambani & more - World’s Top 20 richest people - Business Insider India
